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From rabbit and human cardiac troponin I N-terminal mono and bisphosphorylated peptides were isolated which were obtained from Lys-C pro- 
teinase digests. Two adjacent phosphoserine residues could be localized in each phosphopeptide following further tryptic digestion. The previously 
published sequence of rabbit cardiac troponin I had to be corrected. Two adjacent phosphoserine residues are a common motif in the very similar 
sequences of bovine, rabbit and human cardiac troponln I. The N-terminal sequences are: AcADRSGGSTAG DTVPAPPPVR RRSCPISIPIANY- 
RAY ATEPHAK (bovine), AcADESTDA-AG EARPAPAPVR RRSIP)S(P)ANYRAY ATEPHAK (rabbit), (Ac,A,D/N,G,S,S,D/N,A,A,R) 
EPRPAPAPIR RRS(P)S(P)-NYRAY ATEPHAK (human). 
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1. INTRODUCTION 
Upon &adrenergic stimulation cardiac troponin I, 
the inhibitory subunit of troponin, is phosphorylated in 
mammalian hearts [1,2] which is believed to occur on 
rabbit troponin I at serine-20 [3]. Therefore, a correla- 
tion between phosphorylation of this single amino acid 
and change in contractility was expected which, 
however, could not be clearly demonstrated in hor- 
monally stimulated perfused hearts 141. 
Skeletal muscle troponin I does not contain the N- 
terminal region present in the heart isoform. Therefore, 
cardiac troponin I is an excellent heart-specific cell 
marker which can be detected in blood plasma of pa- 
tients with acute myocardial infarction [9]. Antibodies 
against phosho- and dephospho troponin I may even 
allow to analyze the hormonal status of a heart. A 
prerequisite is the localization of the phosphorylation 
domain in human troponin I. 
Freshly isolated troponin I from both rabbit and 
bovine heart contains 1.5-l .9 mol of phosphate per mol 
of protein [5,6]. Therefore, it was concluded that in ad- 
dition to phosphoserine-20 a second phosphate residue 
of unknown location is bound in the N-terminal se- 
quence stretching from amino acid 1 to 48 [3]. Recently, 
two adjacent phosphoserine residues in position 23 and 
24 were identified in troponin I from bovine heart [6]. 
However, this phosphorylation domain differs con- 
siderably in its sequence from the phosphorylation site 
of rabbit troponin I [7,8]. The amino acid arrangement 
near phosphorylation sites form recognition domains 
for protein kinases which enhance the pressure to con- 
serve such sites during evolution. The presence of two 
adjacent phosphoserine residues in bovine and only one 
phosphoserine residue in rabbit troponin I contradicts 
this hypothesis. 
In the present publication the location of the second 
in vivo phosphorylation site of rabbit cardiac troponin 
I will be reported requiring a correction of the amino 
acid sequence. Additionally, the phospho~lation do- 
main of human cardiac troponin I will be shown. 
2. MATERIALS AND METHODS 
Freshly excised hearts from rabbits, immediately frozen with liquid 
nitrogen, were stored at - 50°C. Myocardial tissue probes from ex- 
plantated human hearts were obtained from the Herzzentrum Nord- 
rhein Westfalen, Bad Oeynhausen. Troponin I was purified from 
both human and rabbit heart according to [lo). About 350 pg 
troponin I, electrophoretically pure, were obtained from one gram 
wet heart. The protein~ont~~ng fractions were applied on PD-IO 
columns ~h~acia) to remove urea. Troponin I fragments were 
isolated after endoproteinase Lys-C and trypsin digestion as described 
previously @a]. Phospho~rin~con~ing peptides were analyzed 
following S-ethyicysteine modification [6,11,12]. 
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Protein-bound phosphate was determined by the method of [13]. 
Amino acid and sequence analyses were carried out as described 
previously [f&14]. Mass-spectra were recorded on a plasma desorption 
mass spectrometer in the Biomedical Center of the University of Upp- 
sala. 1 mnol of the phosphopeptide was solubilized in 30 ~1 of 0.1% 
(v/v) trifluoroacetic acid. 7 fi of the protein solution were incubated 
with ethanol for 1.5 min before the probe was applied to the mass- 
spectrometer. 
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Fig. 1. Separation of endoproteinase Lys-C peptides from rabbit and 
human cardiac troponin I. 10 mnol of each troponin I from rabbit (A) 
and human cardiac muscle (B) were digested with endoproteinase Lys- 
C as described previously [6]. The peptide mixtures (900 d) were 
separated on a pH-stable Vydac C8 column (4.6 x 250 mm) at a flow 
rate of 1 ml/mh-r. A gradient was applied as indicated. Solvent A con- 
tained 0.2% hexafluoroacetone/NH3, pH 7.8, and solvent B 84% 
acetonitrile, 0.03% hexafluoroacetone/NHs, pH 7.8. 
3. RESULTS 
Troponin I freshly isolated from frozen rabbit heart 
muscle (n = 3) contained about 1.9 mol phosphate per 
mol protein whereas that isolated from frozen human 
heart (n = 5) only 0.2-l .O. In both materials phosphate 
was present as phosphoserine xclusively; the amount 
of phosphate as determined by ashing and of 
phosphoserine as determined by S-ethylcysteine, were 
identical within the standard error of both methods 
(data not shown). 
To localize these phosphoserine residues in rabbit 
and human troponin I fragments obtained by digestion 
with lysine-specific proteinase were separated by revers- 
ed-phase high-performance liquid chromatography 
(Fig. 1). In each chromatogram two peaks, (a and b for 
rabbit or c and d for human), were found to contain one 
or two mols of phosphoserine per mol of lysine (Table 
I) indicating that peptides a and c represent the 
bisphospho~lated and peptides b and d the 
monophospho~lated N-termini of each troponin I, 
respectively. Peptides a and b from rabbit cardiac 
troponin I differ in mass by one phosphate group (Fig. 
2). The determined molecular masses of both these pep- 
tides (4018 and 4098) agree with the amino acid com- 
position (Table I). The calculated molecular mass of the 
N-terminal Lys-C peptide (3444) according to the 
published rabbit cardiac troponin I sequence [7] is 574 
Da smaller than the determined mass of peptide b 
(4018). Therefore the amino acid composition as well as 
Amino acid 
Table I 
Amino acid compositions of phosphoserine-containing peptides from troponin I 
Rabbit cardiac Human cardiac 
Peptide N-terminus Peptide 
a al b l-36 l-31 C cl 
Peptide 
d dl 
Asx 
Glx 
Ser 
Ser(P) 
Cly 
His 
A@ 
Thr 
Ala 
Pro 
Tyr 
Val 
Ile 
LYS 
1.8 0.9 
2.3 
1.0 
2.0 2.1 
1.2 - 
1.1 
;41, - 3.3 
9.7 1.3 
4.0 
2.2 1.0 
1.3 
1.0 - 
1.8 
2.4 
2.2 
1.1 
1.3 
0.9 
;2:) 
9.6 
4.1 
1.8 
1.2 
1.0 
3 
3 
1 
2 
1 
1 
6 
1 
10 
4 
2 
1 
1 
3 
3 
1 
1 
I 
1 
5 
1 
9 
3 
1 
1 
1 
1.6 0.7 
1.7 - 
1.7 - 
2.1 2.0 
1.2 - 
1.0 - 
i;:, - 3.1 
7.4 
4.8 
2.0 1.0 
0.9 - 
1.0 - 
1.2 0.7 
1.2 - 
2.5 0.8 
1.0 1.2 
1.4 - 
1.0 - 
:;94) !.’ 
7.6 - 
5.1 - 
2.1 1.0 
1.0 
1.0 
Mass 4098 n.d. 4018 4098 3444 n.d. n.d. n-d. n.d. 
Amino acid analyses following conversion of phosphoserine to S-ethylcysteine were carried out in duplicate. The amountt of amino acids of the 
Lys-C peptides u-d was related to 1 moi lysine and of the tryptic peptides al, cl and &to 1 mol tyrosine. Values were not corrected for destruction 
and slow liberation. The determined amount of threonine is too high, caused by an unknown ~n~i~tion in all samples and therefore were 
disregarded. The amino acid com~sition of the N-t~minus I- 31 from rabbit cardiic troponin I ~ntaining phosphose~ne-20 [3] was taken from 
[7]. The calculated and determined masses of the N-terminus are given (compare Fig. 2). n.d. = not determined. 
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Fig. 2. Plasma desorption mass spectra of the phosphorylated N- 
terminal peptides II and b from rabbit cardiac troponin I. 230 pmol of 
each peptide a (A) and peptide b (B) were applied. The calculated 
masses of 4098 and 4018, respectively, according to amino acid com- 
position are given in Table I. 
the molecular mass indicate that approximately 5 amino 
acids are present additionally in this peptide. 
The isolated N-terminal Lys-C peptides a, c and d 
were further digested with trypsin. The yield of peptide 
b was too small for further digestion since 90% of 
troponin I from rabbit was obtained in the 
bisphosphorylated form. Peptide al from rabbit (Fig. 
3A), as well as peptide d from human cardiac troponin 
I (Fig. 3B) showed a characteristic ratio of approx- 
imately 3 mol arginine to 2 mol phosphoserine (Table 
I). The monophosphorylated peptide dZ(Fig. 3C) deriv- 
ed from human cardiac troponin I contained only two 
arginine residues. Characteristically the human peptides 
cl and dZ contained no alanine (Table I). Following S- 
ethylcysteine modification all three tryptic phosphopep- 
tides al, cl and dZ were subjected to Edman degrada- 
tion. During degradation of both bisphosphorylated 
peptides from rabbit and human cardiac troponin I 
(Fig. 4A and B) nearly exclusively the phenylhydantoin 
derivatives of S-ethylcysteine (S-Et-Cys) were found in 
cycles 3 and 4. The amount of dithiothreitol-serine 
(DTT-Ser) was less than 20%, free serine was not 
detectable. Thus, in both the rabbit and the human pep- 
tides phosphoserine residues were present at these two 
positions. In agreement with the amino acid composi- 
tion the phosphopeptide from human cardiac troponin 
I showed no alanine residue following the second 
phosphoserine residue (Fig. 4). During Edman degrada- 
tion of the monophosphorylated peptide dZ serine was 
found in cycle 2 and S-ethylcysteine in cycle 3 (Fig. 3C). 
The sequence of the bisphosphorylated peptide de- 
rived from rabbit cardiac troponin I is incompatible 
with the published sequence [7]. However, it is identical 
to the sequence of the corresponding peptide from 
bovine cardiac troponin I. Of the five postulated addi- 
tional amino acids four were identified within the tryp- 
tic phosphopeptide from rabbit cardiac troponin I 
(Table I). The fifth amino acid, a proline residue, was 
determined following alanine- in the peptide aZZ(Fig. 
3A, sequence data not shown). The corresponding tryp- 
tic fragment from human cardiac troponin I showed a 
C I 1 
Time [min] 
Fig. 3. Separation of the tryptic fragments from the phosphoserine-containing troponin I peptides a (rabbit), peptide c and d (human). 1 .O nmol 
peptide u (A), 0.9 nmol peptide c (B) and 2.3 nmol peptide d (C) were digested with trypsin as described previously [6]. The digestion mixtures 
were injected on a Vydac Cl8 column 218TP5415 (4.6 X 150 mm) using the indicated gradient from solvent A (0.09% trifluoroacetic acid) to sol- 
vent B (84% acetonitrile, 0.08% trifluoroacetic acid). The flow rate was 1 ml/min. 
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Fig. 4. Sequence analysis of the tryptic peptides al, eland dZ. Samples 
were sequenced following derivatization of phosphoserine residues to 
S-ethylcysteine. 1.2 nmol peptide al (A) was applied, the repetitive 
yield was 68%. 0.2 nmol peptide cl(B) was sequenced with a resulting 
repetitive yield of 97%. 0.6 nmol peptide dZ (C) was applied, the 
calculated repetitive yield was 84%. DMPTU, dimethylphenylthi- 
ourea; DPTLJ, diphenylthiourea; DTT-Ser, dithiothreitol-serine; S- 
Et-Cys, S-ethylcysteine. 
very similar amino acid sequence: alanine-ll is ex- 
changed against proline and vahne-18 against 
isoleucine. Sequences of N-terminal blocked tryptic 
peptides have not been determined. 
4. DISCUSSION 
Strong alkaline conditions as employed in the spin- 
ning cup sequencer results in dehydroalanine formation 
by &elimination of phosphoserine. When present N- 
terminally the formed dehydroalanine rearranges and 
yields a pyruvyl end group which blocks further sequen- 
cing. It explains why extreme difficulties existed in 
determining the location of phosphoserine residues in 
the primary structure. The S-ethylcysteine method over- 
comes this problem. As demonstrated in Fig. 4 two ad- 
jacent phosphoserine residues or a serine residue 
followed by phosphoserine were easily detected in the 
rabbit and human troponin I sequence. 
Indeed, due to the correction of the rabbit troponin 
I sequence all three sequences, that of bovine, rabbit 
and human, are very similar (Fig. 5). Characteristically, 
there exists a proline-rich region upstream of the 
phosphorylation domain formed by three arginine and 
two serine residues. The cluster of helix breaking pro- 
line residues may change the structure of the N- 
terminus in such a way that the following phosphoryla- 
tion domain can adapt to the catalytic center of protein 
kinases. Indeed, these two serine residues can be 
phosphorylated by the CAMP-dependent, cGMP- 
dependent protein kinase and protein kinase C [15]. 
Furthermore, the bound phosphate groups are exposed 
on the surface of the protein as can be judged from 31P 
NMR studies [ 161. In vitro phosphorylation of troponin 
I yields the bisphosphorylated product exclusively [IS] 
vice versa dephosphorylation yields the completely 
dephosphorylated material. The monophosphorylated 
species are not found (Jaquet and Heilmeyer, un- 
published). In contrast, both monophosphorylated 
forms of troponin I are found in the freshly isolated 
protein [6,15]. It indicates that these two serine residues 
are phosphorylated and dephosphorylated ifferential- 
Bonne cardiac [6,81 
2,':" 37 
AcADRSGGSTAG DTVPAPPPVR RRSSANYRAY ATEPHAK 
PP 
20 31 
Rabbit cardiac [3,71 AcADESRDA-AG EARPAPA-VR R-S--D-RAY ATEPHAK 
P 
2223 36 
Rabbit cardiac, corrected AcADESRDA-AG EARPAPAPVR RR%ANYRAY ATEPHAK 
PP 
2223 36 
Human cardiac LAc,A,D/N,G,S,S,D/N,A,A,R) EPRPAPAPIR RR%-NYRAY ATEPHAK 
PP 
Fig. 5. Comparison of the N-terminal phosphorylation sites from rabbit, bovine and human cardiac troponin I. The amino acid sequences were 
aligned to maximize homology. No sequence could be determined for the N-terminal blocked peptide, therefore the amino acid composition is given 
in parentheses. The N-terminal acetylgroup of rabbit troponin I was determined by plasma desorption mass spectrometry. 
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ly. It explains why no linear correlation between 
phosphate incorporation and change in contractility 
was observed in perfused rabbit hearts 141. 
Heart contractility is influenced by two hormonal 
signals triggered by W- and /3-adrenergic receptor oc- 
cupation. The corresponding two signal pathways 
merge at troponin; maybe, differential phosphorylation 
of two serine residues on troponin I is the molecular 
equivalent of signal attenuation observed in heart per- 
fusion studies [ 171. 
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